Clinic-Based Cases with Frontotemporal Dementia Show Increased Cerebrospinal Fluid Tau and High Apolipoprotein E ε4 Frequency, but No Tau Gene Mutations-Reference-Cited by-同舟云学术

Clinic-Based Cases with Frontotemporal Dementia Show Increased Cerebrospinal Fluid Tau and High Apolipoprotein E ε4 Frequency, but No Tau Gene Mutations

Published:2001-04 Issue:2 Volume:168 Page:413-418
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Froelich Fabre Susanne,Forsell Charlotte,Viitanen Matti,Sjögren Magnus,Wallin Anders,Blennow Kaj,Blomberg Marie,Andersen Christian,Wahlund Lars-Olof,Lannfelt Lars

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference45 articles.

1. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: A community based follow up study;Andreasen;J. Neurol. Neurosurg. Psychiatry,1998

2. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology;Arai;Biochem. Biophys. Res. Commun.,1997

3. Association of an extended haplotype in the tau gene with progressive supranuclear palsy;Baker;Hum. Mol. Genet.,1999

4. Biological markers for the diagnosis of Alzheimer's disease;Bancher;J. Neural Transm. Suppl.,1998

5. Direct genetic evidence for involvement of tau in progressive supranuclear palsy: European Study Group on Atypical Parkinsonism Consortium;Bennett;Neurology,1998

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia;Diagnostics;2023-01-17

2. Frontotemporal dementia;Neurogenetics, Part II;2018

3. Glial contributions to neurodegeneration in tauopathies;Molecular Neurodegeneration;2017-06-29

4. Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins;Journal of Lipid Research;2017-05

5. Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration;Oncotarget;2017-04-21